Alexandria Real Estate Equities Inc vs Axogen Inc — how do they compare? Alexandria Real Estate Equities Inc trades at $48.5 (market cap $8.32B), while Axogen Inc trades at $48.35 (market cap $2.59B). The key difference: Alexandria Real Estate Equities Inc is far larger — about 3.2× Axogen Inc's market cap, and Alexandria Real Estate Equities Inc pays a 5.96% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| ARE | AXGN | |
|---|---|---|
Market Cap | $8.32B | $2.59B |
Sector | Real Estate | Technology |
52-Week High | $87.45 | $48.48 |
52-Week Low | $40.41 | $14.16 |
Enterprise Value | $21.02B | $2.50B |
Dividend Yield | 5.96% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.
The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.
Trailing returns across standard periods
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
Read more on ARE →Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →